Diagnostic performance of microRNA-29a in active pulmonary tuberculosis: a systematic review and meta-analysis

Authors

  • Xiaoying Li The Affiliated Hospital of Southwest Medical University https://orcid.org/0000-0002-8410-5007
  • Yuehong Xu Chongqing General Hospital
  • Pu Liao The Affiliated Hospital of Southwest Medical University

DOI:

https://doi.org/10.1016/

Keywords:

Tuberculosis, microRNA-29a, Diagnosis, Meta-analysis

Abstract

Background: In recent years, more and more studies have shown that microRNA-29a (miRNA-29a) can be used as a potential biomarker for active tuberculosis, but the results of these studies are not consistent. Objective: To comprehensively evaluate the value of miRNA-29a in the diagnosis of active tuberculosis by metaanalysis. Methods: The databases of CNKI, WanFang, PubMed, The Cochrane Library, Web of Science and EMBASE were searched for relevant studies. Studies were screened strictly according to inclusion and exclusion criteria. QUADAS-2 scale was used to evaluate the quality of the included studies. Data were extracted and analyzed by MetaDiSc 1.4 and Stata 16.0 software. Results: 13 articles were included, including a total of 1598 subjects, including 872 active tuberculosis patients and 726 controls. The combined sensitivity and specificity of miRNA-29a in the diagnosis of active tuberculosis were 78 % and 76 %, respectively, and the area under the overall summary receiver operating characteristic curve was 0.8564. Conclusion: miRNA-29a can be used as a biomarker for the diagnosis of active tuberculosis.

Downloads

Download data is not yet available.

Downloads

Published

2023-05-06

Issue

Section

Review Articles

How to Cite

Li, X., Xu, Y., & Liao, P. (2023). Diagnostic performance of microRNA-29a in active pulmonary tuberculosis: a systematic review and meta-analysis. Clinics, 78, 100290. https://doi.org/10.1016/